{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:55:23Z","timestamp":1791197723017,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T00:00:00Z","timestamp":1442448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Enterprise and Innovation Centre at St Georges University of London"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/13\/24\/30124"],"award-info":[{"award-number":["FS\/13\/24\/30124"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.atherosclerosis.2015.08.010","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T16:12:43Z","timestamp":1439050363000},"page":"563-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development"],"prefix":"10.1016","volume":"242","author":[{"given":"Christopher","family":"Huggins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Peri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Cockerill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grisha","family":"Pirianov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ejvs.2014.08.029","article-title":"Update on screening for abdominal aortic aneurysm: a topical review","volume":"48","author":"Svensj\u00f6","year":"2014","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib2","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.ATV.0000085631.76095.64","article-title":"Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice","volume":"23","author":"Saraff","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.164.2.558","article-title":"Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex","volume":"164","author":"Ohashi","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib4","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1074\/jbc.M100099200","article-title":"The extra domain A of fibronectin activates Toll-like receptor 4","volume":"276","author":"Okamura","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.ATV.0000251608.09329.9a","article-title":"Role of the Toll-like receptor 4\/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages","volume":"27","author":"Suganami","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib6","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib7","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","article-title":"Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation","volume":"105","author":"Edfeldt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib8","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/ATVBAHA.111.238642","article-title":"MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4","volume":"31","author":"Owens","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib9","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E","volume":"101","author":"Michelsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCRESAHA.107.158220","article-title":"Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction","volume":"102","author":"Timmers","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib11","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/CCM.0b013e3181e941f6","article-title":"Biomarkers as end points in clinical trials of severe sepsis: a garden of forking paths","volume":"38","author":"Salluh","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/SHK.0b013e318227980e","article-title":"Influence of severity of illness on the effects of eritoran tetrasodium (E5564) and on other therapies for severe sepsis","volume":"36","author":"Kalil","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/jm801333m","article-title":"Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization","volume":"52","author":"Piazza","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib14","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.addr.2012.05.009","article-title":"Cationic lipids activate intracellular signaling pathways","volume":"64","author":"Lonez","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib15","doi-asserted-by":"crossref","first-page":"12337","DOI":"10.1021\/bi901601b","article-title":"Evidence of a specific interaction between new synthetic antisepsis agents and CD14","volume":"48","author":"Piazza","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/glia.20699","article-title":"Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice","volume":"56","author":"Bettoni","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib17","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1042\/BST0381390","article-title":"Exploring the LPS\/TLR4 signal pathway with small molecules","volume":"38","author":"Peri","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib18","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1161\/CIRCULATIONAHA.109.852467","article-title":"Rosiglitazone reduces the development and rupture of experimental aortic aneurysms","volume":"119","author":"Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib19","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/cyto.a.20952","article-title":"Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1\u03b2, TNF-\u03b1, and LPS","volume":"77","author":"Mak\u00f3","year":"2010","journal-title":"Cytom. A"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2012.07.034","article-title":"Rosiglitazone negatively regulates c-Jun N-terminal kinase and toll-like receptor 4 proinflammatory signalling during initiation of experimental aortic aneurysms","volume":"225","author":"Pirianov","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib21","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/ATVBAHA.112.00009","article-title":"Elevation of plasma high-density lipoproteins inhibits development of experimental abdominal aortic aneurysms","volume":"32","author":"Torsney","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/08830185.2012.706761","article-title":"Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities","volume":"31","author":"Moghimpour Bijani","year":"2012","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tcm.2004.01.002","article-title":"Angiotensin II-mediated development of vascular diseases","volume":"14","author":"Daugherty","year":"2004","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.colsurfb.2014.03.025","article-title":"Synthesis and in\u00a0vitro and in\u00a0vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system","volume":"118","author":"Ha\u0142upka-Bryl","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib25","doi-asserted-by":"crossref","unstructured":"Trzpis K, Kasprzycka E, Skotnicka B, Hassmann-Pozna\u0144ska E, Wysocka J, Expression of Toll-like receptors on peripheral blood white cells in acute otitis media, Otolaryngol Pol n.d.;68:77\u201382. doi:10.1016\/j.otpol.2013.06.006.","DOI":"10.1016\/j.otpol.2013.06.006"},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib26","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1021\/jm401006s","article-title":"Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update","volume":"57","author":"Peri","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1191\/1358863x02vm413ra","article-title":"Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease","volume":"7","author":"Manning","year":"2002","journal-title":"Vasc. Med."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib28","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1161\/01.ATV.20.12.2527","article-title":"Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells","volume":"20","author":"Cho","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1196\/annals.1383.031","article-title":"Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice","volume":"1085","author":"Yoshimura","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib30","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1042\/BST0351515","article-title":"Structure-function relationships of Toll-like receptor domains through homology modelling and molecular dynamics","volume":"35","author":"Kubarenko","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib31","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/CIRCRESAHA.112.280399","article-title":"\u03b2-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice","volume":"112","author":"Trivedi","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1172\/JCI38136","article-title":"TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice","volume":"120","author":"Wang","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib34","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1074\/jbc.C400503200","article-title":"Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling","volume":"280","author":"Naiki","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4238\/2014.January.28.13","article-title":"TLR4\/NF-\u03baB signaling pathway-mediated and oxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein endothelial cells","volume":"13","author":"Feng","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib36","doi-asserted-by":"crossref","first-page":"17079","DOI":"10.1074\/jbc.M310859200","article-title":"Hyaluronan fragments stimulate endothelial recognition of injury through TLR4","volume":"279","author":"Taylor","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib37","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/ATVBAHA.111.224907","article-title":"Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease","volume":"31","author":"Zheng","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.010_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1024\/0301-1526\/a000326","article-title":"Tanshinone IIA attenuates elastase-induced AAA in rats via inhibition of MyD88-dependent TLR-4 signaling","volume":"43","author":"Shang","year":"2014","journal-title":"Vasa"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T21:56:15Z","timestamp":1617486975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015300733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0021915015300733"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.010","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}